tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX

Pacira Pharmaceuticals (PCRX) Financial Statements

310 Followers

Pacira Pharmaceuticals Financial Overview

Pacira Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.775; its P/E ratio is 36.96; Pacira Pharmaceuticals is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $0.66. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 163.93M$ 169.47M$ 160.34M$ 171.96M$ 167.47M
Gross Profit$ 124.18M$ 104.65M$ 99.21M$ 85.90M$ 116.79M
EBIT$ 23.54M$ 45.57M$ -26.23M$ -9.81M$ 11.02M
EBITDA$ 42.68M$ 65.34M$ -5.02M-$ 31.22M
Net Income Common Stockholders$ 17.57M$ 25.76M$ -19.54M$ -10.10M$ -693.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 235.19M$ 220.77M$ 174.00M$ 288.65M$ 328.73M
Total Assets$ 1.53B$ 1.54B$ 1.52B$ 1.68B$ 1.73B
Total Debt$ 590.30M$ 620.71M$ 625.16M$ 763.39M$ 821.64M
Net Debt$ 355.11M$ 399.95M$ 451.17M$ 474.74M$ 492.91M
Total Liabilities$ 702.91M$ 734.41M$ 755.38M$ 1.68B$ 964.24M
Stockholders Equity$ 831.55M$ 807.98M$ 768.04M$ 775.01M$ 770.12M
Cash Flow-
Free Cash Flow$ 41.04M$ 51.71M$ 945.00K$ 36.55M$ 37.47M
Operating Cash Flow$ 44.44M$ 55.12M$ 7.51M$ 42.04M$ 42.65M
Investing Cash Flow$ -4.34M$ -4.29M$ 77.80M$ 11.19M$ -47.52M
Financing Cash Flow$ -27.79M$ 440.00K$ -153.91M$ -58.51M$ -7.78M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Pacira Pharmaceuticals Debt to Assets

Pacira Pharmaceuticals Cash Flow

Pacira Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis